Bat genomes illuminate adaptations to viral tolerance and disease resistance.

Publication date: Jan 29, 2025

Zoonoses are infectious diseases transmitted from animals to humans. Bats have been suggested to harbour more zoonotic viruses than any other mammalian order. Infections in bats are largely asymptomatic, indicating limited tissue-damaging inflammation and immunopathology. To investigate the genomic basis of disease resistance, the Bat1K project generated reference-quality genomes of ten bat species, including potential viral reservoirs. Here we describe a systematic analysis covering 115 mammalian genomes that revealed that signatures of selection in immune genes are more prevalent in bats than in other mammalian orders. We found an excess of immune gene adaptations in the ancestral chiropteran branch and in many descending bat lineages, highlighting viral entry and detection factors, and regulators of antiviral and inflammatory responses. ISG15, which is an antiviral gene contributing to hyperinflammation during COVID-19 (refs. ), exhibits key residue changes in rhinolophid and hipposiderid bats. Cellular infection experiments show species-specific antiviral differences and an essential role of protein conjugation in antiviral function of bat ISG15, separate from its role in secretion and inflammation in humans. Furthermore, in contrast to humans, ISG15 in most rhinolophid and hipposiderid bats has strong anti-SARS-CoV-2 activity. Our work reveals molecular mechanisms that contribute to viral tolerance and disease resistance in bats.

Open Access PDF

Concepts Keywords
Bats Adaptations
Immunopathology Antiviral
Isg15 Bat
Viral Bats
Zoonoses Genomes
Humans
Immune
Inflammation
Isg15
Mammalian
Resistance
Rhinolophid
Species
Tolerance
Viral

Semantics

Type Source Name
disease MESH Zoonoses
disease MESH infectious diseases
disease MESH Infections
disease MESH inflammation
disease IDO quality
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH COVID-19
disease IDO infection
disease IDO role
disease IDO protein
drug DRUGBANK Coenzyme M
disease MESH respiratory insufficiency
disease IDO history
disease MESH Cancer
disease MESH viral infection
disease IDO replication
pathway REACTOME Metabolism
pathway REACTOME Immune System
disease IDO site
drug DRUGBANK Fenamole
disease IDO immune response
drug DRUGBANK Hyaluronic acid
disease IDO production
disease IDO biological regulation
disease IDO developmental process
pathway REACTOME Reproduction
disease IDO leukocyte mediated immunity
disease IDO homo sapiens
drug DRUGBANK Alpha-Linolenic Acid
drug DRUGBANK L-Cysteine
disease IDO host
drug DRUGBANK ANX-510
pathway REACTOME Release
disease IDO innate immune response
disease MESH autoimmune disease
disease MESH cytokine storms
drug DRUGBANK Myricetin
drug DRUGBANK L-Leucine
drug DRUGBANK Papain
disease IDO process
drug DRUGBANK Gentian violet cation

Original Article

(Visited 1 times, 1 visits today)